Annual Total Long Term Liabilities
$102.42 M
-$18.09 M-15.01%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual total long term liabilities is $102.42 million, with the most recent change of -$18.09 million (-15.01%) on December 31, 2023.
- During the last 3 years, IPHA annual total long term liabilities has fallen by -$27.90 million (-21.41%).
- IPHA annual total long term liabilities is now -46.08% below its all-time high of $189.93 million, reached on December 31, 2015.
Performance
IPHA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$90.55 M
-$11.87 M-11.59%
June 30, 2024
Summary
- As of February 7, 2025, IPHA quarterly total long term liabilities is $90.55 million, with the most recent change of -$11.87 million (-11.59%) on June 30, 2024.
- Over the past year, IPHA quarterly long term liabilities has dropped by -$21.95 million (-19.51%).
- IPHA quarterly long term liabilities is now -54.66% below its all-time high of $199.72 million, reached on June 30, 2015.
Performance
IPHA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IPHA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.0% | -19.5% |
| 3 y3 years | -21.4% | -19.5% |
| 5 y5 years | +2.6% | -19.5% |
IPHA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.0% | +12.8% | -24.9% | at low |
| 5 y | 5-year | -21.4% | +47.2% | -30.5% | +87.4% |
| alltime | all time | -46.1% | +3444.1% | -54.7% | +1307.9% |
Innate Pharma SA Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $90.55 M(-11.6%) |
| Dec 2023 | $102.42 M(-15.0%) | $102.42 M(-9.0%) |
| Jun 2023 | - | $112.50 M(-6.6%) |
| Dec 2022 | $120.51 M(+32.8%) | $120.51 M(+27.4%) |
| Jun 2022 | - | $94.57 M(+4.2%) |
| Dec 2021 | $90.77 M(-30.4%) | $90.77 M(-15.3%) |
| Jun 2021 | - | $107.15 M(-17.8%) |
| Dec 2020 | $130.33 M(+87.3%) | $130.33 M(+169.8%) |
| Jun 2020 | - | $48.31 M(-30.6%) |
| Dec 2019 | $69.59 M(-30.3%) | $69.59 M(-20.2%) |
| Jun 2019 | - | $87.25 M(-12.6%) |
| Dec 2018 | $99.79 M(-12.6%) | $99.79 M(+20.7%) |
| Jun 2018 | - | $82.70 M(-27.6%) |
| Dec 2017 | $114.16 M(-9.2%) | $114.16 M(-1.6%) |
| Jun 2017 | - | $116.05 M(-7.7%) |
| Dec 2016 | $125.77 M(-33.8%) | $125.77 M(-15.6%) |
| Jun 2016 | - | $148.96 M(-21.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $189.93 M(+2853.2%) | $189.93 M(-4.9%) |
| Jun 2015 | - | $199.72 M(+3005.4%) |
| Dec 2014 | $6.43 M(-26.3%) | $6.43 M(-17.5%) |
| Jun 2014 | - | $7.79 M(-10.7%) |
| Dec 2013 | $8.72 M(-31.0%) | $8.72 M(+24.3%) |
| Jun 2013 | - | $7.02 M(-44.5%) |
| Dec 2012 | $12.65 M(-45.7%) | $12.65 M(-24.5%) |
| Jun 2012 | - | $16.75 M(-28.1%) |
| Dec 2011 | $23.30 M(+146.1%) | $23.30 M(+197.6%) |
| Jun 2011 | - | $7.83 M(-17.3%) |
| Dec 2010 | $9.47 M(-15.5%) | $9.47 M(+3.2%) |
| Jun 2010 | - | $9.17 M(-18.1%) |
| Dec 2009 | $11.20 M(+19.6%) | $11.20 M |
| Dec 2008 | $9.37 M(+113.8%) | - |
| Dec 2007 | $4.38 M(+16.5%) | - |
| Dec 2006 | $3.76 M(+30.1%) | - |
| Dec 2005 | $2.89 M | - |
FAQ
- What is Innate Pharma SA annual total long term liabilities?
- What is the all time high annual total long term liabilities for Innate Pharma SA?
- What is Innate Pharma SA annual total long term liabilities year-on-year change?
- What is Innate Pharma SA quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Innate Pharma SA?
- What is Innate Pharma SA quarterly long term liabilities year-on-year change?
What is Innate Pharma SA annual total long term liabilities?
The current annual total long term liabilities of IPHA is $102.42 M
What is the all time high annual total long term liabilities for Innate Pharma SA?
Innate Pharma SA all-time high annual total long term liabilities is $189.93 M
What is Innate Pharma SA annual total long term liabilities year-on-year change?
Over the past year, IPHA annual total long term liabilities has changed by -$18.09 M (-15.01%)
What is Innate Pharma SA quarterly total long term liabilities?
The current quarterly long term liabilities of IPHA is $90.55 M
What is the all time high quarterly long term liabilities for Innate Pharma SA?
Innate Pharma SA all-time high quarterly total long term liabilities is $199.72 M
What is Innate Pharma SA quarterly long term liabilities year-on-year change?
Over the past year, IPHA quarterly total long term liabilities has changed by -$21.95 M (-19.51%)